secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inhibikase Therapeutics, Inc. (IKT)
CIK:        0001750149
Form:       8-K
Filed at:   2024-12-05T23:59:59+00:00
Accession:  0001193125-24-271609
Event type: other_material
Sentiment:  neutral
Materiality: 0.05
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Inhibikase terminates unused ATM facility; no impact on capital
---------------------------------------------------------------

- Terminated ATM agreement with H.C. Wainwright effective Dec 11, 2024.
- Original ATM limit was $5.66M; only $849k sold before reduction to $50k.
- No shares sold under ATM since May 20, 2024.
- Termination ends ability to issue equity at market via this facility.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750149/000119312524271609/0001193125-24-271609-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750149/000119312524271609/d914736d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-271609

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer